Cofoe Medical Technology Co., Ltd. convened its 2026 Third Extraordinary General Meeting (EGM) on 18 September 2026 in Changsha, Hunan. Shareholders representing 127.62 million shares—56.44% of the 226.10 million voting shares outstanding—participated in person or by proxy.
Key resolutions 1. Special resolution – Repurchased A-share utilisation and capital reduction: • 99.97% votes in favour (127.57 million shares), 0.00% against, 0.03% abstained. • Approves changing the purpose of 9.79 million repurchased A shares, cancelling the shares and reducing registered capital, alongside amendments to the Articles of Association.
2. Ordinary resolutions – • 2026 interim profit distribution plan: 99.997% approval. • Appointment of the 2026 overseas auditor: 99.96% approval.
Dividend details • Cash dividend of RMB6.00 (tax-inclusive) per 10 shares (equivalent to RMB0.60 per share) to shareholders on record at 16:30 hrs, 28 September 2026. • Payment date: on or before 16 November 2026. • H-shareholders will receive HK$6.95502 per 10 shares, based on the PBoC average RMB/HKD central parity rate of 1:1.15917 for the five business days preceding the meeting. • H-share register closes 24–28 September 2026; transfers must be lodged by 16:30 hrs, 23 September 2026.
Tax treatment • Non-resident enterprise H-shareholders: 10% PRC withholding tax. • Overseas individual H-shareholders: 10% withholding, unless reduced by bilateral tax treaties. • Northbound Trading investors: 10% withholding on dividends paid in RMB. • Southbound Trading individual investors: 20% withholding; domestic enterprise investors to self-declare taxes.
Share capital context Total issued capital stood at 235.90 million shares (208.90 million A shares, 27.00 million H shares). The 9.79 million repurchased A shares held as treasury or pending cancellation were excluded from voting, leaving 226.10 million eligible shares.
Governance and compliance Vote tabulation for H shares was supervised by Tricor Investor Services Limited, and Hunan Qiyuan Law Firm issued a legal opinion confirming that meeting procedures, attendee qualifications and voting results complied with applicable laws, regulations and the company’s Articles of Association.